Guidelines
Guidelines
EULAR keeps csDMARDs as top PsA drugs
EULAR’s revised psoriatic arthritis recommendations retain methotrexate and other csDMARDS as first-line treatment over TNF inhibitors.
From the Journals
First North American clinical guidelines for hidradenitis suppurativa released
Individualized management is one of the most important parts of taking care of a patient with HS.
Guidelines
EULAR takes SLE guidance to the next level
A lot has changed in 11 years.
Conference Coverage
Choose your steps for treating chronic spontaneous urticaria
CAYMAN ISLANDS – U.S. and European guidelines start with high-dose second-generation antihistamines, but differ in when to introduce other drugs...
Guidelines
ACR, NPF unveil new psoriatic arthritis treatment guideline
This marks the first such recommendations to be assembled using Grading of Recommendations Assessment, Development and Evaluation (GRADE)...
News
Draft guidelines advise HIV screening for most teens and adults
From the Journals
Guideline authors inconsistently disclose conflicts
Review of payment records shows some undisclosed payments of $10,000 or more.
Guidelines
Uveal melanoma: NCCN provides first pathway-based guidelines
Guidelines
Syphilis surge drives USPSTF reaffirmation of early screening for all pregnant women
The prevalence of congenital syphilis was in decline from 2008 to 2012, but then increased by 87% from 2012 to 2016.
Guidelines
AHRQ National Guideline Clearinghouse shutting down
Although some stakeholders are interested in keeping it going, it’s unclear what that would look like and what role, if any, AHRQ would have.
Conference Coverage
Psoriasis duration reflects cardiovascular event risk
For every year of psoriasis, a patient’s risk of a major cardiovascular event climbs an additional 1%.